Summary
Isolated rat hearts were perfused according to the Langendorff technique and both extraneuronal uptake of noradrenaline and COMT were inhibited. The noradrenergic neurones were first prelabelled with 3H-(−)-noradrenaline (13 nmol/1). Thereafter the hearts were submitted to global ischemia (perfusion rate reduced from 5 up to 0.5 ml/min) for 60 min and subsequently reperfused for 5 min. The coronary effluent was continuously collected and analyzed for the appearance of 3H-noradrenaline and its metabolites. 1. Global ischemia was associated with an early release of 3H-noradrenaline. At reperfusion a brisk increase in the FRL of 3H-noradrenaline was observed which may indicate that, on severe restriction in coronary flow, perfusion of the tissue became heterogenous and thus partially masked the amount of 3H-noradrenaline released from the noradrenergic nerve terminals. Gradual reduction in coronary flow also progressively reduced (but did not abolish) the total formation of 3H-DOPEG. 2. The maximal efflux of 3H-noradrenaline was observed during the 1st min of reperfusion whereafter the efflux declined rapidly, indicating a wash-out of transmitter trapped in the extracellular space. The efflux of the lipophilic metabolite 3H-DOPEG, on the other hand, continuously increased during the reperfusion. This was due to both new formation and “wash-out” of 3H-DOPEG retained and/or distributed into the tissue during the period of restricted flow. 3. Neither a reduction of the extracellular calcium concentration (from 2.6 mmol/l to 0.1 mmol/1) nor the presence of the calcium entry blocker verapamil (250 nmol/l) reduced the efflux of 3H-noradrenaline seen during ischemia and reperfusion. 4. Desipramine (100 nmol/l) markedly reduced the ischemia-induced release of 3H-noradrenaline and simultaneously attenuated the formation of 3H-DOPEG. 5. A moderate reduction in the ischemia-induced mobilization of 3H-noradrenaline was seen in hearts perfused with 1μol/l reserpine, whereas the formation of 3H-DOPEG from such hearts was markedly higher than in corresponding controls. Only minor deviations from this pattern was observed when desipramine was present in addition to reserpine. It is concluded that a severe restriction in myocardial perfusion rate is associated with an enhanced net leakage of vesicular noradrenaline. This results in a rise of the free axoplasmic noradrenaline concentration which, in combination with an altered transmembrane sodium gradient, induces an increased local release of noradrenaline partly mediated by a calcium-independent, carrier-mediated outward transport. Desipramine, which inhibits this transport mechanism, may have, in addition to its effect on the membrane carrier, an additional effect in reducing the net leakage of transmitter from storage vesicles. Furthermore, despite severe restriction in coronary flow, and thus oxygen delivery, DOPEG is still formed, possibly as a consequence of the elevated axoplasmic noradrenaline concentration which may in part compensate for a reduced monoamineoxidase activity.
Similar content being viewed by others
Abbreviations
- DOPEG:
-
dihydroxyphenylglycol
- DOMA:
-
dihydroxymandelic acid
- MAO:
-
monoamineoxidase
- COMT:
-
catechol-O-methyltransferase
- OMI:
-
3-O-methoxy-(±)-isoprenaline
- FRL:
-
fractional rate of loss
References
Abrahamsson T, Almgren O, Carlsson L (1983) Ischemia-induced noradrenaline release in the isolated rat heart: Influence of perfusion substrate and duration of ischemia. J Mol Cell Cardiol 15:821–830
Abrahamsson T, Almgren O, Carlsson L (1984) Wash-out of noradrenaline and its metabolites by calcium-free reperfusion after ischaemia. Support of the concept of ischaemia-induced noradrenaline release. Br J Pharmacol 81:022–024
Abrahamsson T, Almgren O, Carlsson L, Svensson L (1985) Antiarrhythmic effect of reducing myocardial noradrenaline stores with α-methyl-meta-tyrosine. J Cardiovasc Pharmacol 7: (Suppl 5) S81-S85
Adler-Graschinsky E, Langer SZ, Rubio MC (1972) Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria. J Pharmacol Exp Ther 180:286–301
Blaustein MP (1979) The role of calcium in catecholamine release from adrenergic nerve terminals. In: Paton DM (ed) The release of catecholamines from adrenergic neurons. Pergamon Press, New York, pp 39–58
Bönisch H, Fuchs G, Graefe K-H (1986) Sodium-dependence of the saturability of carrier-mediated noradrenaline efflux from noradrenergic neurones in the rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 332:131–134
Carlsson L, Abrahamsson T, Almgren O (1985) Local release of myocardial norepinephrine during acute ischemia: An experimental study in the isolated perfused rat heart. J Cardiovasc Pharmacol 7:791–798
Carlsson L, Abrahamsson T, Almgren O (1986) Release of noradrenaline in myocardial ischemia-importance of local inactivation by neuronal and extraneuronal mechanisms. J Cardiovase Pharmacol 8:545–553
Cassis L, Ludwig J, Grohmann M, Trendelenburg U (1986) The effect of partial inhibition of monoamineoxidase on the steady-state rate of deamination of 3H-catecholamines in two metabolizing systems. Naunyn-Schmiedeberg's Arch Pharmacol 333:253–261
Ebert PA, Vanderbeek RB, Allgood RJ, Sabiston DC Jr (1970) Effects of chronic cardiac denervation on arrhythmias after coronary artery ligation. Cardiovasc Res 4:141–147
Fiolet JWT, Bartscheer A, Schumacher CA, Coronel R, Ter Welle HF (1984) The change of free energy of ATP hydrolysis during global ischaemia and anoxia in the rat heart. Its possible role in the regulation of transsarcolemmal sodium and potassium gradients. J Mol Cell Cardiol 16:1023–1036
Friedrich U, Böhnisch H (1986) The neuronal noradrenaline transport system of PC-12 cells: Kinetic analysis of the interaction between noradrenaline, Na+ and Cl− in transport. Naunyn-Schmiedeberg's Arch Pharmacol 333:246–252
Graefe K-H, Stefano FJE, Langer SZ (1973) Preferential metabolism of (−)-3H-noradrenaline through the deaminated glycol in the rat vas deferens. Biochem Pharmacol 22:1147–1160
Göthert M, Nawroth P, Neumeyer H (1979) Inhibitory effects of verapamil, prenylamine and D 600 on Ca 2+-dependent noradrenaline release from the sympathetic nerves of isolated rabbit hearts. Naunyn-Schmiedeberg's Arch Pharmacol 310:11–19
Haeusler G (1972) Differential effect of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals. J Pharmacol Exp Ther 180:672–682
Kirpekar SM, Misu Y (1967) Release of noradrenaline by splenic nerve stimulation and its dependence on calcium. J Physiol (Lond) 188:219–234
Kirpekar SM, Garcia AA, Prat JC (1980) Calcium and frequency-dependent release of norepinephrine. Biochem Pharmacol 29:3029–3031
Kopin IJ (1985) Catecholamine metabolism: Basic aspects and clinical significance. Pharmacol Rev 37:333–364
Kopin IJ, Gordon EK (1962) Metabolism of norepinephrine-3H released by tyramine and reserpine. J Pharmacol Exp Ther 138:351–359
Langer SZ (1974) Selective metabolic pathways for noradrenaline in the peripheral and in the central nervous system. Med Biol 52:372–383
Nayler WG, Sturrock WJ (1984) An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts. J Mol Cell Cardiol 16:331–344
Paton DM (1976) Characteristics of efflux of noradrenaline from adrenergic neurons. In: Paton DM (ed) The mechanism of neuronal and extraneuronal transport of catecholamines. Raven Press, New York, pp 155–174
Raiteri M, del Carmine R, Bertollini A, Levi G (1977) Effect of desmethylimipramine on the release of 3H-noradrenaline induced by various agents in hypothalamic synaptosomes. Mol Pharmacol 13:746–748
Rich TL, Langer GA (1982) Calcium depletion in rabbit myocardium: Calcium paradox protection by hypothermia and cation substitution. Circ Res 51:131–141
Sammet S, Graefe K-H (1979) Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: Kinetic evidence for co-transport. Naunyn-Schmiedeberg's Arch Pharmacol 309:99–107
Sharma AD, Corr PB (1983) Adrenergic factors in arrhythmogenesis in the ischemic and reperfused myocardium. Eur Heart J 4: (Suppl D) 79–90
Schömig A, Dart AM, Dietz R, Mayer E, Kübler W (1984) Release of endogenous catecholamines in the ischemic myocardium of the rat. Circ Res 55:689–701
Steenbergen C, Deleeuw G, Barlow C, Chance B, Williamson JR (1977) Heterogeneity of the hypoxic state in perfused rat heart. Circ Res 41:606–615
Stefano FJE, Trendelenburg U (1984) Saturation of monoamineoxidase by intraneuronal noradrenaline accumulation. Naunyn-Schmiedeberg's Arch Pharmacol 328:135–141
Stute N, Trendelenburg U (1984) The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 327:124–132
Tipton KF (1972) Some properties of monoamineoxidase. Adv Biochem Psychopharmacol 5:11–24
Trendelenburg U, Bönisch H, Graefe K-H, Henseling M (1980) The rate constants for the efflux of metabolites of catecholamines and phenethylamines. Pharmacol Rev 31:179–203
Trendelenburg U, Stefano FJE, Grohmann M (1983) The isotope effect of tritium in 3H-noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 323:128–140
Zeitner CJ, Graefe K-H (1986) Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 334:397–407
Author information
Authors and Affiliations
Additional information
This study was supported by the Deutsche Forschungsgemeinschaft (Gr 490/5-1) and AB Hässle, Mölndal, Sweden
Rights and permissions
About this article
Cite this article
Carlsson, L., Graefe, KH. & Trendelenburg, U. Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 336, 508–518 (1987). https://doi.org/10.1007/BF00169307
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169307